Literature DB >> 10844613

Redistribution of cytoplasmic VEGF to the basolateral aspect of renal tubular cells in ischemia-reperfusion injury.

J Kanellis1, S J Mudge, S Fraser, M Katerelos, D A Power.   

Abstract

BACKGROUND: Vascular endothelial growth factor (VEGF) mRNA and protein expression are increased by hypoxia in a variety of cell types and organs. In the kidney, however, chronic hypoxia does not up-regulate VEGF mRNA. This suggests that VEGF may be regulated by unique mechanisms in the kidney.
METHODS: Unilateral ischemia was induced in rats by vascular cross-clamping (40 min) followed by reperfusion (0, 20, 40, and 80 min). The distribution of VEGF protein was determined by immunohistochemical staining and Western blotting. mRNA was detected by Northern blotting and semiquantitative reverse transcription-polymerase chain reaction (RT-PCR). Immunohistochemical staining for VEGF was verified using two VEGF antibodies. To further substantiate the immunohistochemical findings, laser scanning confocal fluorescence microscopy was used to demonstrate the distribution of VEGF protein in rat renal tubular epithelial cells (NRK52-E) subjected to hypoxia (40 min) and re-oxygenation (0, 5, 20, 40 and 80 min).
RESULTS: Normal kidneys showed diffuse immunohistochemical staining for VEGF in all tubules of the renal cortex and medulla. Following ischemia, staining demonstrated a prominent shift of cytoplasmic VEGF to the basolateral aspect of tubular cells with both VEGF antibodies. The distribution of cytoplasmic VEGF returned to normal following 40 and 80 minutes of reperfusion. Western blots of cytoplasmic samples from ischemic kidneys reperfused for 0 and 20 minutes showed decreased levels of VEGF164 compared with normal (P < 0.01). VEGF164 and VEGF188 levels in the membrane fraction showed no change. Northern blots and semiquantitative RT-PCR showed no significant up-regulation of VEGF mRNA or change in the splice pattern. NRK52-E cells subjected to hypoxia and re-oxygenation for 0 and 5 minutes showed increased staining for VEGF compared with normal, with prominent VEGF staining at the periphery of the cell, similar to the appearance in ischemic kidneys. VEGF staining became more diffuse with further re-oxygenation.
CONCLUSION: Although synthesis of VEGF mRNA and protein is not increased during ischemia reperfusion injury, pre-existing VEGF in the tubular cell cytoplasm redistributes to the basolateral aspect of the cells. These data suggest that the kidney may have evolved unique patterns of VEGF regulation to cope with acute hypoxia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10844613     DOI: 10.1046/j.1523-1755.2000.00103.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  16 in total

1.  Protective effect of milk fat globule-epidermal growth factor-factor VIII after renal ischemia-reperfusion injury in mice.

Authors:  Akihisa Matsuda; Rongqian Wu; Asha Jacob; Hidefumi Komura; Mian Zhou; Zhimin Wang; Md Monowar Aziz; Ping Wang
Journal:  Crit Care Med       Date:  2011-09       Impact factor: 7.598

Review 2.  Potential targeted therapy and diagnosis based on novel insight into growth factors, receptors, and downstream effectors in acute kidney injury and acute kidney injury-chronic kidney disease progression.

Authors:  Li Gao; Xiang Zhong; Juan Jin; Jun Li; Xiao-Ming Meng
Journal:  Signal Transduct Target Ther       Date:  2020-02-14

3.  Proliferation and remodeling of the peritubular microcirculation after nephron reduction: association with the progression of renal lesions.

Authors:  E Pillebout; M Burtin; H T Yuan; P Briand; A S Woolf; G Friedlander; F Terzi
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

4.  Effect of subacute poisoning with lambdacyhalothrin on vascular endothelial growth factor 2 receptor in mice kidneys.

Authors:  Barbara Nieradko-Iwanicka; Maciej Rutkowski
Journal:  BMC Nephrol       Date:  2022-05-28       Impact factor: 2.585

5.  Modulation of inflammatory response by selective inhibition of cyclooxygenase-1 and cyclooxygenase-2 in acute kidney injury.

Authors:  Carla Q Feitoza; Patricia Semedo; Giselle M Gonçalves; Marcos A Cenedeze; Hélady S Pinheiro; Oscar Fernando Pavão Dos Santos; Richardt Gama Landgraf; Alvaro Pacheco-Silva; Niels Olsen Saraiva Câmara
Journal:  Inflamm Res       Date:  2009-08-27       Impact factor: 4.575

6.  Ischemia induces early expression of a new transcription factor (6A3-5) in kidney vascular smooth muscle cells: studies in rat and human renal pathology.

Authors:  Gwenaële Garin; Chérif Badid; Brigitte McGregor; Madeleine Vincent; Sylviane Guerret; Kazem Zibara; Adam Hurlstone; Maurice Laville; John L McGregor
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

7.  miR-218 Expressed in Endothelial Progenitor Cells Contributes to the Development and Repair of the Kidney Microvasculature.

Authors:  Xiaojie Wang; Jialing Liu; Wenqing Yin; Farhiya Abdi; Paul D Pang; Quynh-Anh Fucci; Molly Abbott; Steven L Chang; Graeme Steele; Ankit Patel; Yutaro Mori; Aifeng Zhang; Shikai Zhu; Tzong-Shi Lu; Adam S Kibel; Bin Wang; Kenneth Lim; Andrew M Siedlecki
Journal:  Am J Pathol       Date:  2020-01-20       Impact factor: 4.307

Review 8.  Targeting angiogenesis and lymphangiogenesis in kidney disease.

Authors:  Katsuyuki Tanabe; Jun Wada; Yasufumi Sato
Journal:  Nat Rev Nephrol       Date:  2020-03-06       Impact factor: 28.314

9.  Kallikrein-modified mesenchymal stem cell implantation provides enhanced protection against acute ischemic kidney injury by inhibiting apoptosis and inflammation.

Authors:  Makoto Hagiwara; Bo Shen; Lee Chao; Julie Chao
Journal:  Hum Gene Ther       Date:  2008-08       Impact factor: 5.695

10.  Receptor tyrosine kinases in kidney development.

Authors:  Renfang Song; Samir S El-Dahr; Ihor V Yosypiv
Journal:  J Signal Transduct       Date:  2011-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.